GeneArt.de
Title
GENEART - Excellence in DNA Engineering and Processing: Gene Synthesis, Directed Evolution, Plasmid Services
Description
Field of operations
GENEART provides integrated system solutions for DNA engineering and processing based on the gene synthesis technology platform to deliver improved drugs and biotech products. The services portfolio ranges from the production of optimized synthetic genes and the generation of gene variants and gene libraries in combinatorial biology (gene evolution) right through to the production of DNA-based agents.
Based on its proprietary GeneOptimizer™ sequence design software (patent pending), GENEART optimizes genes according to client demands. The interdisciplinary gene synthesis process combines bioinformatics, organic chemistry and molecular biology to deliver a quality-assured, documented gene optimized for the specific application within 2 - 4 weeks. DNA molecules are manufactured under license from F. Hoffmann-La Roche Ltd. The entire gene synthesis process is certified to DIN ISO 9001:2000.
Taking a master gene as its starting point, GENEART's GeneEvolution business unit can generate individual gene variants, and specific or randomized gene libraries.
Languages
English
